ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
申请人:Celgene Corporation
公开号:EP2536706A1
公开(公告)日:2012-12-26
[EN] ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME<br/>[FR] DÉRIVÉS D'ARYLMÉTHOXYISOINDOLINE ET COMPOSITIONS LES COMPRENANT ET LEURS PROCÉDÉS D'UTILISATION
申请人:CELGENE CORP
公开号:WO2011100380A1
公开(公告)日:2011-08-18
Provided are 4'-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed. The compounds are derivatives of hydroxy thalidomide active against cancer.